Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
International Journal of Clinical Oncology|July 14, 2022
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancerTomoko Yoshihama, Yuka Kuroda, Tatsuyuki Chiyoda, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2021
A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapyKensuke Sakai, Wataru Yamagami, Hiroko Machida, et al.International Journal of Oncology|February 28, 2012
Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review)Kouji Banno, Iori Kisu, Megumi Yanokura, et al.Gynecologic Oncology|July 29, 2020
Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee projectShogo Shigeta, Masako Shida, Satoru Nagase, et al.The Keio Journal of Medicine|March 12, 2025
Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC)Kohei Nakamura, Kenta Masuda, Tomoko Seki, et al.Gynecologic Oncology|December 19, 2023
Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysisShin Nishio, Kenta Murotani, Wataru Yamagami, et al.Cancers|May 21, 2020
Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine CervixHiroko Machida, Koji Matsuo, Shinya Matsuzaki, et al.Obstetrics & Gynecology Science|November 27, 2020
Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registryKeiko Saotome, Wataru Yamagami, Hiroko Machida, et al.Journal of Gynecologic Oncology|September 1, 2022
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profilesTakuro Hirano, Eri Arai, Mao Fujimoto, et al.Molecular and Clinical Oncology|June 19, 2014
A retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcomaWataru Yamagami, Nobuyuki Susumu, Tomomi Ninomiya, et al.Pageof 16